ArticleJournal of veterinary internal medicine2026
Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.
Laura K Massey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.